Skip to main content ↑ ↓
Topic: Gilead buys out rights to cancer therapy from Jounce for $67 million (Read 40 times) previous topic - next topic

Gilead buys out rights to cancer therapy from Jounce for $67 million

Gilead buys out rights to cancer therapy from Jounce for $67 million

[html](Reuters) – Gilead Sciences will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics for $67 million,…[/html]

Source: Gilead buys out rights to cancer therapy from Jounce for $67 million (http://ht**://www.oann.c**/business/gilead-buys-out-rights/?utm_source=rss&utm_medium=rss&utm_campaign=gilead-buys-out-rights)